FAKTOR-OPTIONSSCHEIN - HALEON Stock

Certificat

DE000MG1K2Y9

Market Closed - Börse Stuttgart 10:06:05 2024-05-24 EDT
10.08 EUR +18.03% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month+9.45%
1 month+16.26%
Date Price Change
24-05-24 10.08 +18.03%
24-05-23 8.54 -7.87%
24-05-22 9.27 +6.31%
24-05-21 8.72 +7.52%
24-05-20 8.11 -10.58%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 10:06 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MG1K2Y
ISINDE000MG1K2Y9
Date issued 2024-04-03
Strike 370 p
Maturity Unlimited
Parity 0.05 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.25
Lowest since issue 8.11
Spread 0.07
Spread %0.65%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.23 GBP
Average target price
3.62 GBP
Spread / Average Target
+12.07%
Consensus